Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Chondrocytes
Therapeutic Area: Musculoskeletal Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Biosolution
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 06, 2020
Details:
Under the agreement, Mundipharma obtains the rights to market and distribute CartiLife® in South Korea.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
